نتایج جستجو برای: men2b

تعداد نتایج: 80  

Journal: :Cancer research 2002
Francesca Carlomagno Donata Vitagliano Teresa Guida Fortunato Ciardiello Giampaolo Tortora Giancarlo Vecchio Anderson J Ryan Gabriella Fontanini Alfredo Fusco Massimo Santoro

RET/papillary thyroid carcinoma (PTC) oncogenes, generated by recombination of the tyrosine kinase-encoding domain of RET with different heterologous genes, are prevalent in papillary carcinomas of the thyroid. Point mutations of RET cause multiple endocrine neoplasia type 2 (MEN2) familial cancer syndrome and are found in sporadic medullary thyroid carcinomas. Here, we show that ZD6474, a low ...

Journal: :Clinical chemistry 2006
Rebecca L Margraf Rong Mao W Edward Highsmith Leonard M Holtegaard Carl T Wittwer

BACKGROUND Single-base pair missense mutations in exons 10, 11, 13, 14, 15, and 16 of the RET protooncogene are associated with the autosomal dominant multiple endocrine neoplasia type 2 (MEN2) syndromes: MEN2A, MEN2B, and familial medullary thyroid carcinoma. The current widely used approach for RET mutation detection is sequencing of the exons. METHODS Because RET mutations are rare and the...

Journal: :The oncologist 2014
Anna Znaczko Deirdre E Donnelly Patrick J Morrison

Introduction Multiple endocrine neoplasia type 2 (MEN 2) is a hereditary autosomal dominant endocrine syndrome comprising MEN 2A,MEN2B,and familialmedullary thyroid cancer (MTC) [1, 2]. MEN 2B is characterized by early development of aggressive MTC, and prophylactic total thyroidectomy is advocated by 6 months of age [3–5]. Multiple and bilateral pheochromocytoma occur in 50% of patients, and s...

Journal: :Indian journal of biochemistry & biophysics 2013
Yi Guo Hongbo Xu Zuhai Ren Yongjia Yang Wei Xiong Kai Gao Xiaorong Li Ziqiang Luo Hao Deng

Multiple endocrine neoplasia type 2 (MEN2) is an autosomal dominant disorder that can be distinguished as three different syndromes: multiple endocrine neoplasia type 2A (MEN2A), MEN2B and familial medullary thyroid carcinoma (FMTC). This disorder is usually caused by the mutations of the rearranged during transfection protooncogene gene (RET) or the neurotrophic tyrosine kinase receptor type 1...

2016
Kwaku Dad Abu-Bonsrah Dongcheng Zhang Donald F. Newgreen

Chickens are an invaluable model for studying human diseases, physiology and especially development, but have lagged in genetic applications. With the advent of Programmable Engineered Nucleases, genetic manipulation has become efficient, specific and rapid. Here, we show that the CRISPR/Cas9 system can precisely edit the chicken genome. We generated HIRA, TYRP1, DICER, MBD3, EZH2, and 6 other ...

Journal: :Cancer research 2000
G De Vita R M Melillo F Carlomagno R Visconti M D Castellone A Bellacosa M Billaud A Fusco P N Tsichlis M Santoro

The RET tyrosine kinase is a functional receptor for neurotrophic ligands of the glial cell line-derived neurotrophic factor (GDNF) family. Loss of function of RET is associated with congenital megacolon or Hirschsprung's disease, whereas germ-line point mutations causing RET activation are responsible for multiple endocrine neoplasia type 2 (MEN2A, MEN2B, and familial medullary thyroid carcino...

Journal: :Asian Pacific journal of cancer prevention : APJCP 2015
Marjan Zarif Yeganeh Sara Sheikholeslami Mehdi Hedayati

Thyroid cancer is the most common endocrine neoplasia. The medullary thyroid carcinoma (MTC) is one of the most aggressive forms of thyroid malignancy,accounting for up to 10% of all types of this disease. The mode of inheritance of MTC is autosomal dominantly and gain of function mutations in the RET proto-oncogene are well known to contribute to its development. MTC occurs as hereditary (25%)...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید